|
|
Volumn 9, Issue 4, 2000, Pages 695-711
|
|
Neuroprotection in cerebrovascular disease
|
|
Author keywords
Anti excitotoxic agents; Anti oxidants; Apoptosis; Brain injury; Caspases; Cerebral haemorrhage; Cerebral infarction; Cerebral ischaemia; Cerebral oedema; Cerebrovascular disease; Free radical scavengers; Gene therapy; Glutamate; Hyperbaric oxygen; Hypothermia; NDMA receptors; Neuroprotection; Nitric oxide; Stroke
|
|
Indexed keywords
3 (5 CHLORO 2 METHOXYPHENYL) 3 FLUORO 2,3 DIHYDRO 6 TRIFLUOROMETHYL 1H INDOL 2 ONE;
3,3 BIS(3 FLUOROPHENYL) N METHYLPROPYLAMINE;
ANTIBODY;
ANTIINFLAMMATORY AGENT;
ANTIOXIDANT;
ANTISENSE OLIGONUCLEOTIDE;
AR R15896;
BAY 3702;
BRAIN DERIVED NEUROTROPHIC FACTOR;
CERESIN;
CHELATING AGENT;
CLOMETHIAZOLE;
CYPROS;
EXCITATORY AMINO ACID;
FIBRINOLYTIC AGENT;
FREE RADICAL;
GAVESTINEL;
MONOCLONAL ANTIBODY;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;
NERVE GROWTH FACTOR;
NEUROPROTECTIVE AGENT;
NEUROTROPHIC FACTOR;
NIMODIPINE;
OMEGA CONOTOXIN MVIIA;
ROVELIZUMAB;
SCAVENGER;
SNX 11;
SODIUM CHANNEL BLOCKING AGENT;
SOMATOMEDIN;
STATIN;
TACROLIMUS;
TALAMPANEL;
TRANSFORMING GROWTH FACTOR BETA;
TRAXOPRODIL;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
[1,2,3,4 TETRAHYDRO 7 (1H IMIDAZOL 1 YL) 6 NITRO 2,3 DIOXO 1 QUINOXALINYL]ACETIC ACID;
AMINO ACID TRANSPORT;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
BRAIN INJURY;
BRAIN ISCHEMIA;
CEREBROVASCULAR DISEASE;
CLINICAL TRIAL;
COST OF ILLNESS;
GENE THERAPY;
HUMAN;
HYPERBARIC OXYGEN;
HYPOTHERMIA;
META ANALYSIS;
NEUROPROTECTION;
NONHUMAN;
REPERFUSION INJURY;
REVIEW;
STROKE;
|
|
EID: 0034099547
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.9.4.695 Document Type: Review |
|
Times cited : (31)
|
|
References (37)
|
